Posts filtered by tags: Vyera Pharmaceuticals[x]


 

Pharma Bro Martin Shkreli Banned For Life From Drug Industry in Monopoly Case, Ordered To Pay $64.6 Million

fahrbot-bot writes: A federal judge on Friday ordered notorious "Pharma Bro" Martin Shkreli banned for life from the pharmaceutical industry and also ordered him to pay $64.6 million in profits he earned from hiking the price of the life-saving drug Daraprim by more than 5,000% overnight. The ruling in U.S. District Court in Manhattan came in response to a lawsuit alleging illegal and monopolistic behavior connected with Daraprim by the incarcerated securities fraudster Shkreli. The plaintiffs...
Tags: New York, California, Tech, Manhattan, Federal Trade Commission, Martin Shkreli, Daraprim, U S District Court, Shkreli, Pharma Bro Martin Shkreli, Vyera Pharmaceuticals, Letitia James Shkreli


U.S. FTC, States to Take Shkreli to Trial Over Price Hike

By Brendan PiersonNEW YORK (Reuters) - The U.S. Federal Trade Commission and several states are set to take Vyera Pharmaceuticals founder Martin...
Tags: Reuters, U S Federal Trade Commission, Vyera Pharmaceuticals, Brendan PiersonNEW


‘Pharma Bro’ Case: $40M Settlement Announced Over Daraprim Hike; Martin Shkreli Trial To Move Forward

SACRAMENTO (CBS13) — California’s attorney general has announced a $40 million settlement in the price gouging case against the notorious “Pharma Bro” Martin Shkreli. The settlement was against Vyera Pharmaceuticals and parent company Phoenixus. Shkreli and those pharmaceutical companies were accused in 2015 of buying the rights for the life-saving drug Daraprim, then raising its price by more than 4000% – going from $17.50 a table to $750. “Overnight, Daraprim went from an affordable and access...
Tags: News, California, Local, Syndicated Local, Sacramento, Federal Trade Commission, Ftc, Martin Shkreli, Shkreli, AG, Rob Bonta, Vyera Pharmaceuticals, CBSN Sacramento Feed, Kevin Mulleady, Phoenixus Shkreli


FTC Settles With Vyera Over Daraprim, Shkreli Trial Still On

By Diane Bartz and Jonathan StempelWASHINGTON (Reuters) -The U.S. Federal Trade Commission has reached a settlement with Vyera Pharmaceuticals over...
Tags: Ftc, Reuters, U S Federal Trade Commission, Diane Bartz, Vyera Pharmaceuticals, Jonathan StempelWASHINGTON


FTC Settles With Vyera Over Daraprim, Shkreli Litigation to Go On

WASHINGTON (Reuters) - The U.S. Federal Trade Commission has reached a settlement agreement with Vyera Pharmaceuticals over allegations it sought...
Tags: Washington, Ftc, Reuters The U S Federal Trade Commission, Vyera Pharmaceuticals


Shkreli, Former Company Ask Judge to Find No Wrongdoing in Daraprim Lawsuit

WASHINGTON (Reuters) -Martin Shkreli, in jail on an unrelated matter, his former company Vyera Pharmaceuticals and others asked a judge Monday to...
Tags: Washington, Martin Shkreli, Reuters, Vyera Pharmaceuticals, Daraprim Lawsuit, Shkreli Former Company


Pharma Bro Shkreli Asks Judge to Find No Wrongdoing in Daraprim Lawsuit

WASHINGTON (Reuters) - Jailed "Pharma Bro" Martin Shkreli, his former company Vyera Pharmaceuticals and others asked a judge Monday to find that...
Tags: Washington, Reuters, Pharma Bro Martin Shkreli, Vyera Pharmaceuticals, Daraprim Lawsuit


Bio Roundup: Drug Prices, CRISPR Caveats, Rubius IPO Pop & More

After nearly two years of all smoke, no fire around President Trump’s promise to curtail drug prices, there’s finally some glimmer of action. Pfizer said last week it would halt its price hikes, and Novartis and Merck took similar actions this week. But we still don’t know the details of the administration’s drug-pricing policy, if there is one beyond the blueprint released in May. And we don’t know if the moves by Pfizer, Novartis, and Merck are just for optics, or indicative of deeper industr...
Tags: Deals, Dna, Trends, Merck, Bill Gates, Fda, National, Novartis, Pfizer, Allergan, Biotech, Roundups, Verge Genomics, Life Sciences, Martin Shkreli, Trump


United States: Litigation Wrap: Fourth Quarter 2017 - Hughes Hubbard & Reed LLP

On Sept. 29, Hughes Hubbard led Vyera Pharmaceuticals to a big win when a Manhattan federal judge ruled that Impax Laboratories Inc. could not collect $43 million from Vyera,
Tags: News, United States, Manhattan, Impax Laboratories Inc, Hughes Hubbard, Reed LLP, Vyera Pharmaceuticals


Company founded by Shkreli off the hook in $43M lawsuit

Vyera Pharmaceuticals, formerly known as Turing Pharmaceuticals, does not have to pay Impax Laboratories Inc $43 million in a dispute stemming from Turing founder Martin Shkreli's decision to boost by 5,000 percent the price of a drug Turing bought from Impax, a U.S. judge ruled on Friday.
Tags: Finance, Article, Turing, Martin Shkreli, Turing Pharmaceuticals, Reuters, Shkreli, FBN, Impax Laboratories Inc, Impax, Fbn/markets, FOX BUSINESS/MARKETS, FOX BUSINESS/INDUSTRIES/Health Care, Fox-business/news, A5610187-e25a-40d8-9387-ae8f602a3ae1, Vyera Pharmaceuticals